Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2011Future Microbiology

Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes

View Full Paper
Ask AI
Bookmark
Share

Authors

Matthew E. Falagas
Matthew E. FalagasBoston UniversityDKDrosos E. KarageorgopoulosUniversity of OxfordPNPatrice NordmannUniversité Paris-Sud

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Falagas et al. (2011) studied this question.

synapsesocial.com/papers/6a5f586a7262ef29ca5907cchttps://doi.org/10.2217/fmb.11.49
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of<i>Klebsiella pneumoniae</i>2001 · 1,657 citations
  2. 2Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary2010 · 115 citations
  3. 3Infections with VIM-1 Metallo-β-Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome2009 · 51 citations
  4. 4Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing <i>Klebsiella pneumoniae</i>2010 · 144 citations
  5. 5Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study2008 · 164 citations